Reuters logo
BRIEF-Alere receives FDA clearance for Alere i Influenza A & B 2 rapid molecular test
October 2, 2017 / 11:11 AM / 17 days ago

BRIEF-Alere receives FDA clearance for Alere i Influenza A & B 2 rapid molecular test

Oct 2 (Reuters) - Alere Inc

* Alere receives FDA clearance for Alere I Influenza A & B 2 rapid molecular test

* Alere Inc says ‍will shortly submit an application for CLIA waiver of Alere i Influenza A & B 2 test​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below